Literature DB >> 31439096

Blood Pressure and Marijuana Use: Results from a Decade of NHANES Data.

Denise C Vidot1, Makia Powers2, Raul Gonzalez3, Dushyantha T Jayaweera4, Sabita Roy4, Chunming Dong4, Sarah E Messiah5.   

Abstract

Objectives: After 14 years of no change, new blood pressure (BP) guidelines were released; yet, the impact of marijuana on BP remains unclear. Our objective was to examine the association between marijuana use and BP.
Methods: We analyzed data for adults (N = 10,709; mean age 44.8 years; 50.3% men) who completed 2005-2014 National Health and Nutrition Examination Surveys. Marijuana use was defined as never (no lifetime use), past (lifetime, not in past 30 days), and current (≥ 1 in past 30 days). Frequency of use was categorized based past 30-day use. BP was categorized as elevated BP, Stage 1 hypertension (HTN-I), or Stage 2 hypertension (HTN-II) based on updated guidelines.
Results: Current users had a higher prevalence of elevated BP (19.4%), HTN-I (22.7%), HTN-II (12.9%) than never users (16.1%, 21.4%, and 11.99%) respectively; p = .03). After covariate adjustment, heavy users had 1.80 higher odds of elevated BP than never users (95% CI: 1.13-2.88). There were no statistically significant differences in BP in any other marijuana use category. Conclusions: Driven by heavy use, current users had a higher prevalence of elevated BP than never users. Patients at risk for abnormal BP should use caution when engaging in heavy marijuana use.

Entities:  

Mesh:

Year:  2019        PMID: 31439096     DOI: 10.5993/AJHB.43.5.2

Source DB:  PubMed          Journal:  Am J Health Behav        ISSN: 1087-3244


  2 in total

1.  Associations of Cannabis Use across Adolescence and Early Adulthood With Health and Psychosocial Adjustment in Early Adulthood and Midadulthood in Men.

Authors:  Deborah M Capaldi; Stacey S Tiberio; David Cr Kerr; Lee D Owen
Journal:  Subst Abuse       Date:  2022-06-03

2.  Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists.

Authors:  Arianna Giorgetti; Francesco Paolo Busardò; Roberta Tittarelli; Volker Auwärter; Raffaele Giorgetti
Journal:  Front Psychiatry       Date:  2020-05-25       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.